SCHEMBL24104635

SCHEMBL24104635

CCCCCCCCC[C@H]1CC[C@H](OP(=O)(O)OCC[PH](C)(C)C)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.37
AKT2 P31751 3/20 0.37
AKT3 Q9Y243 3/20 0.37
PIK3R1 P27986 2/20 0.37
PIK3CA P42336 2/20 0.37
PLCG2 P16885 1/20 0.37
GAB1 Q13480 1/20 0.37
MAPK14 Q16539 3/20 0.36
TERT O14746 1/20 0.36
UCHL3 P15374 1/20 0.36
LPAR3 Q9UBY5 5/20 0.36
LPAR1 Q92633 4/20 0.36
LPAR2 Q9HBW0 2/20 0.36
S1PR2 O95136 1/20 0.35
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
S1PR5 Q9H228 1/20 0.35
LPAR5 Q9H1C0 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17817658 1.00 AKT1 (0.37) AKT1AKT2AKT3PIK3R1PIK3CA
SCHEMBL17832987 0.88 AKT1 (0.40) AKT1AKT2AKT3PIK3R1PIK3CA
SCHEMBL17833008 0.85 AKT1 (0.36) AKT1AKT2AKT3PIK3R1PIK3CA
SCHEMBL17817196 0.85 AKT1 (0.36) AKT1AKT2AKT3PIK3R1PIK3CA
SCHEMBL9485449 0.84 S1PR1 (0.43) AKT1MAPK14TERTUCHL3LPAR3
SCHEMBL9485299 0.84 S1PR1 (0.43) AKT1MAPK14TERTUCHL3LPAR3
SCHEMBL17817229 0.82 AKT1 (0.45) AKT1MAPK14TERTUCHL3MEN1
SCHEMBL23016753 0.82 AKT1 (0.45) AKT1MAPK14TERTUCHL3MEN1
SCHEMBL17817209 0.82 AKT1 (0.45) AKT1MAPK14TERTUCHL3MEN1
SCHEMBL24103962 0.76 LPAR3 (0.47) LPAR3LPAR1LPAR2S1PR2S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252290-A2 COMPOSITIONS AND METHODS FOR TREATING NOVEL CORONAVIRUS SARS-COV-2-MEDIATED INFLAMMATORY CONDITIONS GRI BIO, INC. (US) 2021-12-16 WO disclosed